Changes in lipid profile during infliximab and corticosteroid treatment in rheumatoid arthritis

類似資料

• Bone mineral density in patients with rheumatoid arthritis treated with infliximab
  著者:: Vis, M, 等
  出版事項: (2005)
• Adverse events in patients with rheumatoid arthritis treated with infliximab in daily clinical practice
  著者:: Neven, N, 等
  出版事項: (2005)
• Relationship between serum trough infliximab levels, pretreatment C reactive protein levels, and clinical response to infliximab treatment in patients with rheumatoid arthritis
  著者:: Wolbink, G, 等
  出版事項: (2005)
• Infliximab treatment reduces complement activation in patients with rheumatoid arthritis
  著者:: Familian, A, 等
  出版事項: (2005)
• Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFκB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis
  著者:: Vis, M, 等
  出版事項: (2006)